Skip to main content

Advertisement

SpringerLink
Log in

Effects of paracetamol, non-steroidal anti-inflammatory drugs, acetylsalicylic acid, and opioids on bone mineral density and risk of fracture: results of the Danish Osteoporosis Prevention Study (DOPS)

  • Original Article
  • Published:
Osteoporosis International Aims and scope Submit manuscript

Abstract

Summary

Pain medication has been associated with fractures. We found higher weight in paracetamol and non-steroidal anti-inflammatory drugs (NSAID) users and lower vitamin D levels in opioid and acetylsalicylic acid users. None of the pain medications influenced bone mineral density or loss. NSAID were associated with an increased fracture risk.

Introduction

To study the effects of use of paracetamol, non-steroidal anti-inflammatory drugs (NSAID), acetylsalicylic acid (ASA), and opioids on bone mineral density (BMD) and risk of fractures.

Methods

Two-thousand sixteen perimenopausal women followed for 10 years as part of a partly randomised comprehensive cohort study on hormone therapy (HT). BMD was measured at baseline and after 10 years by DXA (Hologic).

Results

Paracetamol users were heavier (70.4 ± 13.4 vs. 67.7 ± 11.9 kg, 2p < 0.01) than non-users. NSAID users were heavier (71.6 ± 15.6 vs. 67.8 ± 11.9 kg, 2p = 0.04) than non-users. ASA users had lower 25-hydroxy-vitamin D (25OHD) levels (21.9 ± 9.3 vs. 25.3 ± 12.4 ng/ml, 2p < 0.01) than non-users. Opioid users had lower 25OHD (21.4 ± 8.4 vs. 25.2 ± 12.3 ng/ml) and lower intake of vitamin D (2.2 ± 1.1 vs. 3.1 ± 3.0 μg/day, 2p < 0.01) than non-users. Despite these differences, no baseline differences were present in spine, hip, forearm or whole body BMD. Over 10 years, no differences were present in BMD alterations except a small trend towards a higher BMD gain in the spine in users of paracetamol, NSAID, ASA, and opioids compared to non-exposed. After adjustment, NSAID exposed sustained more fractures (HR = 1.44, 95% CI 1.07–1.93) than non-users. For users of paracetamol and opioids, a non-significant trend towards more fractures was present after adjustment. For ASA users, no excess risk of fractures was present.

Conclusion

Significant differences exist between subjects exposed to pain medications and non-users. Despite an absence of an effect over time on BMD, users of NSAID experienced more fractures than expected. The reasons for this have to be explored in further studies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Kinjo M, Setoguchi S, Schneeweiss S, Solomon D (2005) Bone mineral density in subjects using central nervous system-active medications. Am J Med 118:1414.e7–1414.e12

    Article  Google Scholar 

  2. Daniell H (2002) Hypogonadism in men consuming sustained-action oral opioids. J Pain 3:377–384

    Article  PubMed  Google Scholar 

  3. Hallinan R, Byrne A, Agho K, McMahon CG, Tynan P, Attia J (2009) Hypogonadism in men receiving methadone and buprenorphine maintenance treatment. Int J Androl 32:131–139

    Article  CAS  PubMed  Google Scholar 

  4. Vestergaard P, Rejnmark L, Mosekilde L (2006) Fracture risk associated with use of morphine and opiates. J Intern Med 260:76–87

    Article  CAS  PubMed  Google Scholar 

  5. Bauer D, Orwoll E, Fox K, Vogt T, Lane N, Hochberg M, Stone K, Nevitt M (1996) Aspirin and NSAID use in older women: effect on bone mineral density and fracture risk Study of Osteoporotic Fractures Research Group. J Bone Miner Res 11:29–35

    Article  CAS  PubMed  Google Scholar 

  6. Carbone L, Tylavsky F, Cauley J, Harris T, Lang T, Bauer D, Barrow K, Kritchevsky S (2003) Association between bone mineral density and the use of nonsteroidal anti-inflammatory drugs and aspirin: impact of cyclooxygenase selectivity. J Bone Miner Res 18:1795–1802

    Article  CAS  PubMed  Google Scholar 

  7. Raisz L (1995) Physiologic and pathologic roles of prostaglandins and other eicosanoids in bone metabolism. J Nutr 125:2024S–2027S

    CAS  PubMed  Google Scholar 

  8. Raisz L (1999) Prostaglandins and bone: physiology and pathophysiology. Osteoarthritis Cartilage 7:419–421

    Article  CAS  PubMed  Google Scholar 

  9. Raisz L (2001) Potential impact of selective cyclooxygenase-2 inhibitors on bone metabolism in health and disease. Am J Med 110(Suppl 3A):43S–45S

    Article  CAS  PubMed  Google Scholar 

  10. van Staa T, Leufkens H, Cooper C (2000) Use of nonsteroidal anti-inflammatory drugs and risk of fractures. Bone 27:563–568

    Article  PubMed  Google Scholar 

  11. Vestergaard P, Rejnmark L, Mosekilde L (2006) Fracture risk associated with use of nonsteroidal anti-inflammatory drugs, acetylsalicylic acid, and acetaminophen and the effects of rheumatoid arthritis and osteoarthritis. Calcif Tissue Int 79:84–94

    Article  CAS  PubMed  Google Scholar 

  12. Aisen P, Schafer K, Grundman M, Pfeiffer E, Sano M, Davis K, Farlow M, Jin S, Thomas R, Thal L (2003) Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial. JAMA 289:2819–2826

    Article  CAS  PubMed  Google Scholar 

  13. Bannwarth B, Treves R, Euller-Ziegler L, Rolland D, Ravaud P, Dougados M (2003) Adverse events associated with rofecoxib therapy: results of a large study in community-derived osteoarthritic patients. Drug Saf 26:49–54

    Article  CAS  PubMed  Google Scholar 

  14. Silberstein S, Tepper S, Brandes J, Diamond M, Goldstein J, Winner P, Venkatraman S, Vrijens F, Malbecq W, Lines C, Visser W, Reines S, Yuen E (2004) Randomized, placebo-controlled trial of rofecoxib in the acute treatment of migraine. Neurology 62:1552–1557

    CAS  PubMed  Google Scholar 

  15. Walker PC, Alrawi A, Mitchell JF, Regal RE, Khanderia U (2005) Medication use as a risk factor for falls among hospitalized elderly patients. Am J Health Syst Pharm 62:2495–2499

    Article  PubMed  Google Scholar 

  16. Barden J, Edwards J, Moore R, McQuay H (2004) Single dose oral diclofenac for postoperative pain. Cochrane Database Syst Rev (2):CD004768.

  17. Hegeman J, van den Bemt BJF, Duysens J, van Limbeek J (2009) NSAIDs and the risk of accidental falls in the elderly: a systematic review. Drug Saf 32:489–498

    Article  CAS  PubMed  Google Scholar 

  18. Hegeman J, Nienhuis B, van den Bemt B, Weerdesteyn V, van Limbeek J, Duysens J (2010) The effect of a non-steroidal anti-inflammatory drug on two important predictors for accidental falls: postural balance and manual reaction time. A randomized, controlled pilot study. Hum Mov Sci 30:384–395

    Article  PubMed  Google Scholar 

  19. García-Martínez O, Díaz-Rodríguez L, Rodríguez-Pérez L, De Luna-Bertos E, Botella CR, Ruiz CC (2010) Effect of acetaminophen, ibuprofen and methylprednisolone on different parameters of human osteoblast-like cells. Arch Oral Biol 56:317–323

    Article  PubMed  Google Scholar 

  20. Díaz-Rodríguez L, García-Martínez O, Arroyo-Morales M, Rubio-Ruiz B, Ruiz C (2010) Effect of acetaminophen (paracetamol) on human osteosarcoma cell line MG63. Acta Pharmacol Sin 31:1495–1499

    Article  PubMed  Google Scholar 

  21. Mosekilde L, Hermann A, Beck-Nielsen H, Charles P, Nielsen S, Sørensen O (1999) The Danish Osteoporosis Prevention Study (DOPS): project design and inclusion of 2016 normal perimenopausal women. Maturitas 31:207–219

    Article  CAS  PubMed  Google Scholar 

  22. Mosekilde L, Beck-Nielsen H, Sørensen O, Nielsen S, Charles P, Vestergaard P, Hermann A, Gram J, Hansen T, Abrahamsen B, Ebbesen E, Stilgren L, Jensen L, Brot C, Hansen B, Tofteng C, Eiken P, Kolthoff N (2000) Hormonal replacement therapy reduces forearm fracture incidence in recent postmenopausal women—results of the Danish Osteoporosis Prevention Study. Maturitas 36:181–193

    Article  CAS  PubMed  Google Scholar 

  23. Brixen K, Nielsen HK, Eriksen EF, Charles P, Mosekilde L (1989) Efficacy of wheat germ lectin-precipitated alkaline phosphatase in serum as an estimator of bone mineralization rate: comparison to serum total alkaline phosphatase and serum bone Gla-protein. Calcif Tissue Int 44:93–98

    Article  CAS  PubMed  Google Scholar 

  24. Lund B, Sorensen O (1979) Measurement of 25-hydroxyvitamin D in serum and its relation to sunshine, age and vitamin D intake in the Danish population. Scand J Clin Lab Invest 39:23–30

    Article  CAS  PubMed  Google Scholar 

  25. Abrahamsen B, Gram J, Hansen T, Beck-Nielsen H (1995) Cross-calibration of QDR-2000 and QDR-1000 dual energy X-ray densitometers for bone mineral and soft tissue measurements. Bone 16:385–391

    Article  CAS  PubMed  Google Scholar 

  26. De Laet C, Kanis J, Oden A, Johanson H, Johnell O, Delmas P, Eisman J, Kroger H, Fujiwara S, Garnero P, McCloskey E, Mellstrom D, Melton LJ III, Meunier P, Pols H, Reeve J, Silman A, Tenenhouse A (2005) Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporosis Int 16:1330–1338

    Article  Google Scholar 

  27. Lovell S, Taira T, Rodriguez E, Wackett A, Gulla J, Singer A (2004) Comparison of valdecoxib and an oxycodone-acetaminophen combination for acute musculoskeletal pain in the emergency department: a randomized controlled trial. Acad Emerg Med 11:1278–1282

    PubMed  Google Scholar 

  28. Vestergaard P (2008) Pain-relief medication and risk of fractures. Curr Drug Saf 3:199–203

    Article  CAS  PubMed  Google Scholar 

  29. Marshall D, Johnell O, Wedel H (1996) Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 312:1254–1259

    Article  CAS  PubMed  Google Scholar 

  30. Dimmen S, Nordsletten L, Engebretsen L, Steen H, Madsen JE (2008) Negative effect of parecoxib on bone mineral during fracture healing in rats. Acta Orthop 79:438–444

    Article  PubMed  Google Scholar 

  31. Dimmen S, Nordsletten L, Madsen JE (2009) Parecoxib and indomethacin delay early fracture healing: a study in rats. Clin Orthop Relat Res 467:1992–1999

    Article  PubMed  Google Scholar 

  32. Bischoff H, Stahelin H, Urscheler N, Ehrsam R, Vonthein R, Perrig-Chiello P, Tyndall A, Theiler R (1999) Muscle strength in the elderly: its relation to vitamin D metabolites. Arch Phys Med Rehabil 80:54–58

    Article  CAS  PubMed  Google Scholar 

  33. Bischoff H, St. helin H, Dick W, Akos R, Knecht M, Salis C, Nebiker M, Theiler R, Pfeifer M, Begerow B, Lew R, Conzelmann M (2003) Effects of vitamin D and calcium supplementation on falls: a randomized controlled trial. J Bone Miner Res 18:343–351

    Article  CAS  PubMed  Google Scholar 

Download references

Financial support

The study was made possible through financial support from the A.P. Møller Foundation (Fonden til Lægevidenskabens Fremme), and by Karen Elise Jensen’s Foundation, the Danish Medical Research Council. Novo Nordisk Denmark, Novartis Denmark, and Leo Denmark provided the study medication free of charge. None of these had any influence on study design and conduct.

Conflicts of interest

None.

Author information

Authors and Affiliations

  1. Department of Endocrinology and Internal Medicine (MEA), Aarhus University Hospital, Aarhus, Denmark

    P. Vestergaard & L. Mosekilde

  2. Department of Endocrinology M, Odense University Hospital, Odense, Denmark

    P. Hermann

  3. Department of Endocrinology, Hvidovre University Hospital, Copenhagen, Denmark

    J.-E. B. Jensen

  4. Department of Cardiology and Endocrinology, Hillerød Hospital, Hillerød, Denmark

    P. Eiken

  5. The Osteoporosis Clinic, Aarhus University Hospital THG, Tage Hansens Gade 2, DK-8000, Aarhus C, Denmark

    P. Vestergaard

Authors
  1. P. Vestergaard
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Hermann
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J.-E. B. Jensen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. P. Eiken
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. L. Mosekilde
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to P. Vestergaard.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vestergaard, P., Hermann, P., Jensen, JE.B. et al. Effects of paracetamol, non-steroidal anti-inflammatory drugs, acetylsalicylic acid, and opioids on bone mineral density and risk of fracture: results of the Danish Osteoporosis Prevention Study (DOPS). Osteoporos Int 23, 1255–1265 (2012). https://doi.org/10.1007/s00198-011-1692-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-011-1692-0

Keywords

Search

Navigation